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Abstract
Objectives Standardization is an important milestone in the validation of DWI-based parameters as imaging biomarkers 
for renal disease. Here, we propose technical recommendations on three variants of renal DWI, monoexponential DWI, 
IVIM and DTI, as well as associated MRI biomarkers (ADC, D, D*, f, FA and MD) to aid ongoing international efforts on 
methodological harmonization.
Materials and methods Reported DWI biomarkers from 194 prior renal DWI studies were extracted and Pearson correla-
tions between diffusion biomarkers and protocol parameters were computed. Based on the literature review, surveys were 
designed for the consensus building. Survey data were collected via Delphi consensus process on renal DWI preparation, 
acquisition, analysis, and reporting. Consensus was defined as ≥ 75% agreement.
Results Correlations were observed between reported diffusion biomarkers and protocol parameters. Out of 87 survey 
questions, 57 achieved consensus resolution, while many of the remaining questions were resolved by preference (65–74% 
agreement). Summary of the literature and survey data as well as recommendations for the preparation, acquisition, process-
ing and reporting of renal DWI were provided.
Discussion The consensus-based technical recommendations for renal DWI aim to facilitate inter-site harmonization and 
increase clinical impact of the technique on a larger scale by setting a framework for acquisition protocols for future renal 
DWI studies. We anticipate an iterative process with continuous updating of the recommendations according to progress in 
the field.
Keywords Biomarker · DWI · ADC · IVIM · DTI
Introduction
Diffusion-weighted (DWI) magnetic resonance imaging 
(MRI) has been shown to provide differentiated informa-
tion on the microstructure of kidney tissue. Furthermore, 
significant efforts have been made to adopt DWI-based 
parameters as an MR biomarker for functional renal 
imaging [1–6]. However, to successfully translate the 
research results of renal DWI to clinical practice, there 
are still some challenges to overcome. Firstly, acquisi-
tion protocols vary between research groups and reflect 
local practice and expertise. Secondly, patient prepa-
ration, data post-processing and image analysis are not 
standardized, with several approaches being used by dif-
ferent research groups. As has been recognized by other 
consortium efforts [7–9], our motivation behind prioritiz-
ing standardization of these processes is the generation 
of reliable MRI biomarkers that are ready to be broadly 
utilized in multi-site studies. When achieved, the data gen-
erated from standardized study protocols will sufficiently 
increase the evidence base to determine threshold values 
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for DWI-based parameters, to differentiate between renal 
pathologies. Histopathological correlation should also 
continue to be performed to ensure diagnostic validation 
of the MRI biomarkers. With the aim to move toward a 
standardization and to facilitate the validation of DWI-
based parameters as a renal MRI biomarker, an interna-
tional, multidisciplinary group of renal imaging research-
ers with experience and/or ongoing work in renal DWI 
was recently formed as part of the ‘PARENCHIMA’ (the 
European Cooperation in Science and Technology) COST 
action (www.renal mri.org).
As a first step in this endeavour, Caroli et al. [10] pub-
lished a review and statement paper reflecting the cur-
rent state of research to assess diffuse renal pathology by 
renal DWI. The work summarizes the acquisition protocols 
used in human renal DWI studies up to August 2017 (172 
studies) involving both healthy subjects and patients with 
renal disease. It highlights the large diversity in acqui-
sition protocols, patient preparation and image post-pro-
cessing techniques, as well as the lack of “gold standard” 
for the measurement of in vivo renal DWI. This diversity 
of acquisition protocols across studies has led to a vari-
ability of acquired quantitative renal diffusion parameters, 
which is summarized in the detailed supplement mate-
rial of the review [10]. Therefore, a further mission of the 
PARENCHIMA initiative is building consensus on renal 
DWI acquisition protocol, patient preparation and post-
processing techniques.
In this work, a consensus on recommended acquisition 
protocol for renal DWI was formed consistent with the 
consensus-building goals of the Delphi process [11–13]. 
The design of the surveys for the consensus building was 
informed by a literature review (extending the prior review 
until November 2018) that aimed to identify which acquisi-
tion parameters had the most impact on DWI measurements. 
For the development of the recommendations, the three most 
common variants of renal DWI techniques used in the lit-
erature were considered: (1) monoexponential model with 
parameter apparent diffusion coefficient (ADC); (2) biex-
ponential model or IVIM (intravoxel incoherent motion) 
model with the parameters water diffusion in the tissue (D), 
flowing fraction (f) and pseudodiffusion (D*); and (3) dif-
fusion tensor imaging (DTI) with mean diffusivity (MD) 
and fractional anisotropy (FA). All three variants of renal 
DWI techniques aim to estimate a diffusion constant of water 
in tissue. However, in all models this diffusion constant is 
named differently (ADC, D, and MD). ADC quantification 
methods considering a non-Gaussian DWI signal behavior 
are not covered in these recommendations given their more 
preliminary stage of investigation and are not deemed as ripe 
for standardization as the other methods described above. 
We summarize the three common renal DWI approaches 
and associated quantification methods below.
Monoexponential ADC
This quantification model for diffusion-weighted MRI is 
the most popular due to its simplicity and modest acqui-
sition requirements. The monoexponential ADC model 
assumes a uniform Gaussian displacement distribution of 
the water molecules corresponding to a monoexponential 
diffusion-weighted signal decay of the MR signal. The 
computation of the monoexponential ADC is based on the 
Stejskal–Tanner equation [14]:
where Sb is the diffusion-weighted signal intensity, S0 is 
the signal intensity without a diffusion weighting (b = 0 s/
mm2), b is the diffusion weighting strength (in s/mm2), and 
 ADCmono is the apparent diffusion coefficient of water within 
the observed image voxel.
For renal tissue, the monoexponential model is known 
to be insufficient to describe the diffusion-weighted sig-
nal decay, with IVIM effects occurring at low b values 
(< 200 s/mm2) [15] and non-Gaussian effects possibly 
occurring at high b values (> 800 s/mm2). However, as a 
single parameter estimation, the monoexponential model 
provides relatively robust ADC and requires only moderate 
signal-to-noise ratio on DWI.
Given the contrast effects mentioned above, the esti-
mated ADC is strongly dependent on the choice of selected 
b-values [15, 16] and no consensus exists with regard to 
the choice and number of b values in a renal DWI acquisi-
tion protocol. Taking into account Eq. (1), a set of mini-
mum two b values is enough to reach a stable diffusion 
signal [16, 17] for the quantification of ADC. However, 
most authors prefer to describe the diffusion signal decay 
more precisely by including more b values in the acquisi-
tion protocol. Considering possible anisotropic diffusion, 
it is common practice to measure the b values in several 
orthogonal directions during the ADC acquisition [15, 16].
Intravoxel incoherent motion (IVIM)
First described by Le Bihan et al. [18] in 1986 the IVIM 
model is another option to interpret the physiological 
underpinning of the diffusion signal. Since the initial stud-
ies in human subjects by Muller et al. in 1998 [19] and 
later by Thoeny et al. in 2006 [20] showing the potential of 
the IVIM model to interpret diffusion signal in the kidney, 
this quantification has been demonstrated to improve the 
representation of the diffusion-weighted signal in renal 
tissue compared to the ADC [21–23].
(1)
Sb
S0
= e−bADCmono
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IVIM considers the diffusion signal originating from 
two different compartments. One compartment reflects 
the slow thermal diffusion in the tissue (D), hindered or 
restricted by local microstructure. The second compart-
ment considers the fast molecule movement associated 
with incoherent flow in the microvasculature or renal 
tubules that mimic random water motion assuming that 
many vessel and tubules orientations are present within 
the voxel (quantified by the pseudodiffusion, D* and the 
flowing fraction, f).
This method of quantification utilizes a biexponential 
decay, describing the overall diffusion-weighted signal as 
the sum of the diffusion and flowing components:
where Sb is the diffusion-weighted signal intensity, S0 is 
the signal intensity without a diffusion weighting (b = 0 s/
mm2), b is the diffusion weighting strength (in s/mm2), D 
is the water diffusion in the tissue (slow component), D* is 
the pseudodiffusion (fast component), and f is the flowing 
fraction.
To quantify IVIM parameters, a minimum of four b 
values are needed to determine all unknown parameters 
in Eq. (2), which typically extends the acquisition time in 
comparison to the monoexponential ADC. Furthermore, 
there is no universally accepted algorithm yet to calculate 
IVIM quantitative parameters. In many studies, a so-called 
“segmented fitting” or “2-step” approach is used to calcu-
late the IVIM parameters (2), due to its extended stability 
and faster fitting [24–27]. In the “segmented fitting”, a 
threshold b value is defined to separate flowing from dif-
fusion effects (microcirculation-induced decay assumed 
negligible above this threshold). However, although D is 
more stable in the “segmented fitting”, than in others, the 
estimates of f and D* can be biased depending on thresh-
old choice. More recently, Bayesian probability-based fit-
ting methods have been explored, with or without fixing 
of the pseudodiffusion coefficient (this has shown higher 
precision/accuracy, and low inter-subject variability [28]).
Other, more complex, extended IVIM models can 
be found in the literature that aim to incorporate more 
characteristics of functioning renal tissue into the signal 
description. Three compartment models include an addi-
tional component taking into account multiple sources of 
intravoxel incoherent motion, e.g., due to the glomeru-
lar flow [29, 30], vascular vs. tubular flow, or residual fat 
signal [31]. Other extended models combine IVIM with 
diffusion anisotropy for a more comprehensive description 
of both structural and microcirculation features [32, 33]. 
These models are mentioned here solely to indicate cur-
rent research frontiers as they require further investigation 
(2)
Sb
S0
= (1 − f )e−bD + fe−bD
∗
before they can be pursued in the context of consensus 
standardization.
Diffusion tensor imaging (DTI)
Measurement of the directional dependence (anisotropy) of 
apparent diffusion in tissue microstructure provides a marker 
of that tissue’s integrity and thereby its clinical function. 
Diffusion tensor imaging (DTI) quantitatively measures and 
maps the anisotropy imposed on water diffusion by a tissue’s 
microstructure.
For DTI analysis, diffusion-weighted signals along sev-
eral diffusion directions are acquired and fit to a 3 × 3 sym-
metric tensor model [34, 35].
where D̄ is the symmetric diffusion tensor with elements 
Dij determined by the linear set of equations generated by 
the set of ADC measurements along each diffusion gradient 
direction [36] ĝ:
More generally, all gradients (imaging and diffusion 
weighting) can be taken into account by computing the full 
b-matrix of their diffusion weighting:
The eigenvalues of this tensor describe the maximal, 
intermediate, and minimal diffusion values, with eigenvec-
tors reflecting their corresponding orientation. The primary 
eigenvector, associated with the largest eigenvalue, indicates 
the orientation of maximal diffusion.
where MD or mean diffusivity is the average of the diffusion 
coefficients and 1, 2, 3 are the eigenvalues.
(3)D̄ =
⎛⎜⎜⎝
Dxx Dxy Dxz
Dyx Dyy Dyz
Dzx Dzy Dzz
⎞⎟⎟⎠
(4)ADCn = �gn
†
⋅ D̄ ⋅ �gn =
∑
ij
gi,ngj,nDij.
(5)− ln
(
S
S0
)
=
∑
ij
bijDij,
bij =
TE
∫
0
ki(t)kj(t)dt,
ki(t) =
t
∫
0
Gi
(
t�
)
dt�.
(6)MD =
1
3
(
1 + 2 + 3
)
,
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Another parameter, called fractional anisotropy (FA), 
reflects the amount of diffusion directivity in DTI studies 
(0 = complete isotropy, 1 = complete anisotropy) and is cal-
culated by
where again MD is the average of the diffusion coefficients, 
a DTI-specific ADC equivalent and 1, 2, 3 are the 
eigenvalues.
Several studies have demonstrated that DTI provides 
powerful biomarkers of diffusion isotropy in the cortex and 
anisotropy in the renal medulla [15, 16, 22, 37–43]. This 
behavior is consistent with the known structural organiza-
tion of medullary constituents such as the tubular loops of 
Henle, collecting ducts, and vascular vasa recta, which have 
an inward radial pattern toward the renal pelvis.
As with many diffusion biomarkers, FA and MD depend 
on the number and magnitude of the applied b values [38, 
42, 44]. As diffusion anisotropy is a key target of DTI, 
acquisition of multiple diffusion directions (minimally 6) 
is required for tensor computation. However, while some 
studies of diffusion direction choice in renal DTI have been 
performed supporting at least 12 directions [45], determina-
tion of an optimal number or choice of b values and direc-
tions for renal DTI, analogous to comprehensive efforts in 
the brain [28] or muscle [46], has not yet been performed.
Materials and methods
Literature review and data extraction
To justify the motivation for the standardization process, 
assess the state of the renal DWI literature, and provide input 
to subsequent recommendations, we summarize reported 
DWI biomarkers from a wide range of prior renal DWI stud-
ies assessing diffuse renal diseases. These efforts build upon 
reviews and meta-analyses that have aimed to understand 
the variability of reported renal diffusion biomarkers in the 
literature [4, 15, 23].
A systematic review and analysis of the literature (using 
the same search criteria in PubMed as previously used by 
Caroli et al. [10], but extending those until November 2018) 
was carried out.
Specifically, papers were categorized according to their 
protocol and quantification scheme as either monoexpo-
nential DWI (113 studies), DTI (40 studies), or IVIM (41 
studies). From each paper, we extracted protocol parameters 
including full b value ranges, repetition times (TR), echo 
(7)
FA =
√
3
2
×
√(
1 −MD
)2
+
(
2 −MD
)2
+
(
3 −MD
)2
√
2
1
+ 2
2
+ 2
3
,
times (TE), number of gradient directions and field strength. 
The distribution of b value ranges was extracted for each 
DWI model for visualization. Additionally, DWI biomarkers 
were also extracted for cortex, medulla, and whole kidney 
(as available in each study), reporting values in healthy adult 
controls. For each b value range, the maximum and average 
b values were also computed. Monoexponential DWI stud-
ies provided ADC values [20, 21, 43, 47–61], DTI studies 
provided MD and FA values [29, 32, 33, 38, 42, 45, 62–71] 
and IVIM studies provided D, f and D* values [20, 21, 28, 
29, 32, 42, 43, 54, 55, 68, 71–78].
Following data extraction, correlations were computed in 
healthy volunteers only via Pearson correlation coefficients 
with the following protocol parameters: (1) TR; (2) TE; (3) 
average b value; (4) maximum b value; (5) transverse relax-
ation factor T2 = exp (− TE/T2t); (6) T1 = [1 − exp (− TR/
T1t)], where T2t = 87 ms and T1t = 1147 ms were taken as 
representative relaxation times for renal tissue at 3.0 T [79]. 
After correlation with individual protocol parameters, cor-
relations were computed between diffusion biomarkers and 
all possible products or ratios of the protocol parameters 
(52 combinations in all). Correlation coefficients R and sig-
nificance levels p were derived for each correlation using 
the Igor Pro 7 software (Wavemetrics, Inc., Lake Oswego, 
OR USA). Significant correlations were noted both with-
out (p < 0.05) and with Bonferroni correction for multiple 
comparisons (p < 0.05/52 = 0.00096). Finally, all diffusion 
biomarkers from healthy volunteers were grouped according 
to field strength (1.5 T or 3.0 T) and compared for differ-
ences with a two-tailed Student’s t test, for which significant 
differences are indicated for p < 0.05.
Description of survey process
As described in the accompanying covering letter by Sour-
bron et al. and in keeping with the ‘approximation of a two-
step modified Delphi method [80]’ for consensus building, a 
survey was circulated using a publicly available tool (Google 
Forms) to a range of renal imaging researchers with expe-
rience and/or ongoing activity in renal diffusion imaging. 
In addition to offering participation to all members of the 
PARENCHIMA collaboration, every effort was made to 
invite at least one researcher or corresponding author from 
each group contributing to the literature as surveyed previ-
ously [10]. Two rounds of surveys were circulated over a 
period of 4 months. Between the first and second circula-
tion and following review of initial results with the ASL, 
BOLD and T1/T2 panels at a meeting in Aarhus, the list 
of questions was increased and refined to avoid ambigu-
ity and increase the likelihood of reaching consensus on as 
many items as possible. The surveys included questions on: 
respondent training, patient preparation, image acquisition, 
diffusion parameters, analysis, and reporting. The full list of 
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questions from the final circulation is provided in “Results” 
along with summarized results, percentage agreement, no 
basis and disagreement for all responses, as well as per-
centage agreement and disagreement without abstentions. 
Nearly, all questions tested level of agreement or disagree-
ment qualitatively. In the first circulation, five options were 
provided (strongly agree/agree/neutral/disagree/strongly 
disagree). In the second circulation, the available responses 
were simplified and allowed for abstention (agree/disagree/I 
have insufficient experience to make a recommendation). 
Other questions focused on the preferred field strength 
or allowed multiple selections to test support of multiple 
related issues (e.g., reported parameters). Text comments 
were also collected on sets of questions of similar topics. 
For both rounds, responses were aggregated following the 
completion of the survey. The first round survey was issued 
on 11 January 2019, and the second on 27 March 2019; both 
were open for approximately 1 month.
After excluding abstentions, the level of agreement or 
disagreement as a percentage of all responses was cal-
culated for each question. Responses for which either 
agreement or disagreement reached 75% or higher were 
deemed to have achieved consensus. Responses that 
related to one that has already reached consensus were 
deemed to have been resolved. For responses with agree-
ment levels between 60 and 75%, a ‘preference’ was indi-
cated but without the full weight of consensus. Similarly, 
other responses mutually exclusive from a preference or 
reaching lower levels of agreement on the same topic were 
deemed to have been resolved by that preference. Finally, 
the combination of all of these directly or indirectly 
Fig. 1  Distributions of diffusion MRI sampling in renal DWI litera-
ture studies. b value distributions used in studies reporting a ADC 
values, b DTI metrics, or c IVIM metrics. In the ‘bubble’ plots, the 
size of the circle reflects the amount of studies utilizing that b value. 
d Distribution of diffusion directions employed; ADC and IVIM stud-
ies dominantly employed three directions, with DTI studies employ-
ing more directions
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resolved questions was considered to generate a set of 
recommendations.
Results
Literature review
Figure 1 shows the distributions of b value sampling and 
diffusion directions from all renal studies considered (con-
trol and patient related). Monoexponential DWI and IVIM 
studies have featured a continuous range of b values, while 
DTI studies have used a sparser selection, consistent with 
more time devoted to directional sampling. Finally, the 
majority of ADC and IVIM studies used three orthogonal 
directions for isotropic imaging. Since many of these stud-
ies employ inline processing with vendor software, the 
three directions are typically immediately averaged, both 
for convenience and for enhanced signal-to-noise ratio, 
to generate approximate ‘trace-weighted’ images prior to 
generation of ADC maps. DTI studies used six directions 
most often, but studies using as many as 30 directions have 
also been reported. While 6 directions are the bare mini-
mum required for tensor calculation, other supplemental 
criteria have been suggested; for example, a minimum of 
12 directions have been suggested to eliminate orientation 
bias in tensor results [81]. As a range of optimization stud-
ies have investigated, parameter estimation quality (both 
accuracy and precision) depends crucially on sufficient 
signal-to-noise ratio (SNR) [16, 17, 82, 83]. While thresh-
olds and criteria vary, minimum SNR levels of 20–30 are 
frequently suggested for advanced renal DWI.
Table 1 shows the results of the diffusion biomarker 
vs. protocol parameter correlations in healthy volunteers. 
All correlation results are shown for individual protocol 
parameters and biomarkers, and additional correlations are 
shown with protocol parameter combinations that provided 
higher correlation coefficients. The primary protocol ele-
ment correlation with reported diffusion biomarkers is 
average b value, which significantly correlated nega-
tively with tissue diffusivity D [Cx (cortex): R = − 0.506, 
p = 0.03; Md (medulla): R = − 0.528, p = 0.02] and posi-
tively with flow fraction f (Cx: R = 0.687, p = 0.002; 
Md: R = 0.566, p = 0.01). These correlations may have 
contributions from partial sampling of the IVIM signal 
response, with higher b value ranges providing better esti-
mates of both slow and fast diffusion components. Con-
versely, if b values are sampled beyond the appropriate 
SNR level, Rician noise [84] (or more complex noise pat-
terns accompanying image reconstruction [85]) bias can 
lower ADC or D values and inflate f values. Similar nega-
tive correlation trends (p < 0.1) are seen between cortical 
ADC (R = − 0.378, p = 0.08) or cortical MD (R = − 0.531, 
p = 0.05) and maximum b value. Transverse relaxation 
effects cause secondary correlations of flowing fraction 
with echo time TE (R = 0.474, p = 0.055) or equivalently 
T2 decay factor (R = − 0.495, p = 0.04), likely due to 
reduction of the more rapidly relaxing tissue compartment, 
as quantified by Lemke et al. [17], and supported by the 
disparate relaxation times of renal tissue [79] and serum 
blood [86] or urine [87–89]. Another potential modulator 
of contrast is diffusion time, which is lengthened at larger 
echo time, though the role of this parameter in renal tis-
sue has not been conclusively mapped out. Combining b 
value and sequence timing factors together showed some 
amplified correlations, particularly for flow fraction and 
tissue diffusivity. In some cases, increasing T1 recov-
ery increased flow representation and therefore higher 
f and ADC. Finally, a combination of relaxation factors 
and average b value showed a negative correlation trend 
(R = − 0.463, p = 0.07) with medullary FA, consistent with 
a modulation in flow effects on diffusion anisotropy. Fig-
ure 2 shows example correlations between renal DWI bio-
markers in the literature and protocol parameters. As these 
variations of acquisition protocols and DWI biomarkers 
should be avoided in the translation of renal DWI to clini-
cal practice, the present manuscript describes ongoing 
efforts to maximize lessons learned from existing work 
to facilitate multi-site consistency through standardized 
acquisition, analysis, and reporting guidelines.
Table 2 shows summarized diffusion biomarkers in cor-
tex and medulla in healthy volunteers from the literature 
review, stratified by field strength (1.5 T or 3.0 T). The only 
cases showing significant differences were IVIM pseudo-
diffusion (D*) and DTI mean diffusivity (MD) in cortex, 
both of which were higher at 1.5 T than 3.0 T.
Survey results
The second-round survey included 21 respondents from 21 
institutions in 8 different countries on 3 continents. 9 of 21 
(43%) were radiologists, while 13/21 (57%) were physi-
cists (11), biomedical engineers (1), or mathematicians (1). 
71% of the respondents used renal diffusion for volunteer 
research, 76% used it for patient research, 38% used it for 
clinical practice, and 14% used it for clinical trials.
For the second-round survey, among the 87 questions 
testing levels of agreement, 23 reached consensus agree-
ment and 18 reached consensus disagreement. These results 
also resolved 16 other questions on the same topics as the 
“parent” consensus questions. For the remaining ques-
tions, if preferences are made for 17 questions, the remain-
ing 13 questions are resolved. The fully aggregated survey 
responses, as well as text comments provided, are included 
as supplementary material, with Table 3 summarizing results 
of agree/disagree questions (with those reaching consensus 
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highlighted). Regarding magnetic field strength, a consensus 
majority (81%) responded either 1.5 T or 3.0 T as accept-
able. Regarding reporting preferences, all suggested acquisi-
tion details (matrix, image orientation, fat suppression mode, 
averages, slice thickness, resolution, field of view, TR, 
TE, number and choice of b values, and number of direc-
tions) received consensus support to be reported. Report-
ing biomarkers in both cortex and medulla was supported 
by consensus. Regarding processing, motion correction 
algorithm, processing software, IVIM fit algorithm, and 
IVIM fit option received consensus support to be reported. 
Regarding biomarkers’ summary statistics, mean, median, 
and standard deviation values received consensus support to 
be reported. There are a range of topics that did not reach the 
level of consensus, including slice thickness, repetition time 
TR, number of signal averages, breathing mode, separate 
Table 1  Correlations between reported renal diffusion metrics in the 
literature from cortex (Cx) or medulla (Md) regions of healthy vol-
unteer kidneys and the corresponding studies’ protocol parameters 
average b value (ave b val), maximum b value (max b val), echo time 
(TE), repetition time (TR), T2-weighting factor (T2f), and T1-weight-
ing factor (T1f) (see text for calculation of relaxation weighting fac-
tors)
Pearson correlation coefficients R, significance levels from two-sided t test, p, and number of studies contributing N are shown for the following 
diffusion parameters: apparent diffusion coefficient (ADC), IVIM tissue diffusivity (D), IVIM flow fraction (f), IVIM pseudodiffusivity (D*), 
DTI mean diffusivity (MD), and DTI fractional anisotropy (FA). Significant correlations (p < 0.05) are highlighted in bold and moderate trends 
(p < 0.1) in italics
ADC D f D* MD FA
R p N R p N R p N R p N R p N R p N
Ave b val
 Cx − 0.162 0.47 22 − 0.506 0.03 18 0.687 0.002 18 − 0.268 0.40 12 − 0.147 0.62 14 0.144 0.60 16
 Md − 0.154 0.56 17 − 0.528 0.02 18 0.566 0.01 18 − 0.319 0.31 12 0.093 0.75 14 − 0.296 0.27 16
Max b val
 Cx − 0.378 0.08 22 − 0.245 0.33 18 0.285 0.25 18 0.106 0.74 12 − 0.531 0.05 14 0.102 0.71 16
 Md − 0.223 0.39 17 − 0.260 0.30 18 0.281 0.26 18 0.239 0.46 12 0.161 0.58 14 − 0.192 0.45 16
TE
 Cx 0.220 0.37 19 0.149 0.57 17 0.474 0.055 17 − 0.262 0.44 11 0.036 0.90 14 − 0.087 0.75 16
 Md 0.345 0.19 16 0.163 0.53 17 0.150 0.57 17 − 0.272 0.42 11 − 0.152 0.61 14 0.216 0.42 16
TR
 Cx 0.225 0.44 14 − 0.270 0.30 17 0.097 0.71 17 0.392 0.23 11 − 0.168 0.57 14 0.038 0.89 16
 Md 0.039 0.90 12 − 0.186 0.48 17 0.043 0.87 17 0.459 0.16 11 − 0.060 0.84 14 − 0.292 0.27 16
T2f
 Cx − 0.223 0.36 19 − 0.151 0.56 17 − 0.495 0.04 17 0.249 0.46 11 − 0.083 0.78 14 0.102 0.71 16
 Md − 0.378 0.15 16 − 0.158 0.55 17 − 0.155 0.55 17 0.257 0.45 11 0.127 0.67 14 − 0.255 0.34 16
T1f
 Cx − 0.016 0.96 14 − 0.142 0.59 17 0.171 0.51 17 0.298 0.37 11 − 0.268 0.35 14 0.126 0.64 16
 Md 0.110 0.73 12 − 0.129 0.62 17 0.018 0.95 17 0.274 0.42 11 − 0.116 0.69 14 0.079 0.77 16
Ave b × TE
 Cx 0.007 0.98 19 − 0.338 0.19 17 0.713 0.001 17 − 0.395 0.23 11 − 0.168 0.57 14 0.086 0.75 16
 Md 0.506 0.046 16 − 0.331 0.20 17 0.501 0.04 17 − 0.457 0.16 11 0.001 1.0 14 − 0.216 0.42 16
Ave b × T2f
 Cx − 0.067 0.78 19 − 0.701 0.003 17 0.435 0.08 17 − 0.184 0.59 11 − 0.106 0.72 14 0.200 0.46 16
 Md 0.107 0.69 16 − 0.741 0.001 17 0.559 0.02 17 − 0.228 0.50 11 0.167 0.57 14 − 0.357 0.18 16
Ave b × T2f/T1f
 Cx 0.262 0.37 14 − 0.479 0.05 17 0.223 0.39 17 − 0.338 0.31 11 0.141 0.63 14 0.030 0.91 16
 Md 0.175 0.59 12 − 0.503 0.04 17 0.427 0.09 17 − 0.340 0.31 11 0.253 0.38 14 − 0.463 0.07 16
Ave b × T1f/T2f
 Cx 0.691 0.006 14 − 0.381 0.13 17 0.682 0.003 17 − 0.174 0.61 11 − 0.269 0.35 14 0.133 0.63 16
 Md 0.660 0.02 12 − 0.369 0.15 17 0.477 0.05 17 − 0.240 0.48 11 − 0.049 0.87 14 − 0.204 0.45 16
Max b × T1f/T2f
 Cx 0.110 0.71 14 − 0.155 0.55 17 0.547 0.02 17 0.171 0.62 11 − 0.539 0.047 14 0.088 0.75 16
 Md 0.293 0.36 12 − 0.150 0.57 17 0.310 0.23 17 0.236 0.48 11 − 0.015 0.96 14 − 0.163 0.55 16
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vs. combined protocols, diffusion gradient waveform, the 
number and highest b value employed, number of diffusion 
directions for DTI, and aspects of ROI prescriptions.
Considering the literature trends, consensus views, 
preferences, comments and practical aspects surrounding 
future evidence generation, recommendations are given 
in Table 4 for monoexponential DWI, IVIM, and DTI pro-
tocols. For many of the issues guiding protocol selection, 
the survey process provided clear indications of consensus 
choices (Table 3). For those topics not reaching consensus, 
we combine lesser-weighted preferences, practical issues, 
and information from text survey responses to synthesize 
recommendations. For acquisition, the consensus includes 
pulse sequences, RF coils, in-plane matrix/resolution, slice 
coverage, parallel imaging acceleration, fat suppression, 
echo time, and absence of cardiac gating. Strong preference 
(62%) was given for > 4 mm slice thickness, though some 
respondents expressed a desire for lower values when fea-
sible. Strong preference (67% agreement) was also given 
for a TR = 2–4 s. Given some contribution of T1 weighting 
to parameter variability, we have suggested a standardized 
repetition time TR = 4 s. Breathing mode did not reach con-
sensus; however, strong preference (70%) was given to res-
piratory gating and free breathing (66%). Free breathing was 
noted to be acceptable in cases of renal allograft imaging. 
We have recommended respiratory gating when available 
and free breathing with post hoc unilateral motion correction 
when not available (which was separately recommended by 
Fig. 2  Correlations between renal diffusion MRI metrics and proto-
col parameters from the literature from cortex, medulla, and whole 
kidney tissue in healthy adults. a ADC, b IVIM tissue diffusivity D, 
c DTI fractional anisotropy FA, and d IVIM flow fraction f vs. aver-
age or maximum b value with relaxation weighting terms. Inter-study 
variation can be reduced when desired for larger evidence generation 
using more standardized protocols
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consensus). Regarding field strength, consensus approval for 
either 1.5 T or 3.0 T was found (81%), and only minimal dif-
ferences were observed in the literature (Table 2). The SNR 
advantage of higher field is balanced by other disadvantages 
for DWI such as susceptibility-induced image distortion. 
Correspondingly, either field strength is deemed acceptable 
and investigators suggested to employ whichever is better 
equipped with hardware or software elements consistent 
with recommendations herein.
Discussion
The design of diffusion MRI protocols for renal imaging 
remains controversial, with some support for separate pro-
tocols for each diffusion technique and slightly more sup-
port for combined protocols. Similarly, separate protocols 
for ‘standardized’ efforts and exploratory research had only 
50% support. Since deriving all measures from a combined 
protocol requires more sophisticated workflows than are 
universally available and consistent with the goals of gen-
erating generalizable evidence, we have thus recommended 
parsimonious protocols for monoexponential DWI, IVIM, 
and DTI studies. As noted below, however, the encoding 
parameters suggested have commonalities (e.g., b values) 
that may allow pooling of analogous biomarkers and consist-
ency with advanced protocols involving combined encoding.
As mentioned in “Results”, field strength was not a 
crucial determining factor in either the diffusion metrics 
reported in the literature (only 2 out of 24 comparisons 
showed significant differences in Table 2) or in the con-
sensus preferences of the survey respondents. The field dif-
ferences observed in D* and MD in cortex in the literature 
values most likely arise from indirect effects of differential 
relaxation weighting of flow and structural compartments 
with field, since both have field-dependent relaxation times 
as discussed above. Thus, currently field strength is not a 
stringent requirement for standardization, although the 
growing technological prevalence of higher field (3.0 T) 
may make the point moot.
Diffusion weighting (choice of b values) is a crucial ele-
ment of diffusion MRI protocols. For monoexponential 
DWI studies, consensus was found for more than 2 b values, 
including values < 200 s/mm2, with strong preference for a 
maximum b value of 800 s/mm2. For IVIM studies, con-
sensus was found for a number of b values greater than 6 b 
values, with highest preference for more than 8. Finally, for 
DTI studies, preference was given to more than 2 b values 
(61%), with a maximum b value of 600 s/mm2 (59%). Six 
directions were deemed insufficient for DTI (76%), with a 
slight preference for more than 12 directions (63%). In addi-
tion to these indications from our panel, we may also take 
guidance from optimization studies on renal DWI sampling 
[16, 17] that emphasized the importance of several key b 
value regimes: low (0–200 s/mm2) intermediate (200–400 s/
mm2), and high (600–800 s/mm2). Finally, we deem it valu-
able to suggest common encoding parameters between tech-
niques (monoexponential DWI, IVIM, DTI) where possible 
Table 2  Comparisons between 
reported renal diffusion metrics 
in the literature from cortex 
or medulla regions of healthy 
volunteer kidneys at different 
field strengths (1.5 or 3.0 T)
Mean and standard deviation values, significance levels from two-sided t test, p, and number of studies 
contributing N are shown for the following diffusion parameters: apparent diffusion coefficient (ADC), 
IVIM tissue diffusivity (D), IVIM flow fraction (f), IVIM pseudodiffusivity (D*), DTI mean diffusivity 
(MD), and DTI fractional anisotropy (FA). Significant field differences (p < 0.05) are highlighted in bold. 
ADC, D, D*, and MD values are given in  10−6 mm2/s, f is given in %, and FA is unitless
ADC D f D* MD FA
Cortex
 1.5 T
  Mean ± SD 2056 ± 285 1966 ± 72 19.9 ± 3.2 50,800 ± 13,454 2508 ± 86 0.208 ± 0.045
  N 12 7 7 4 4 4
 3.0 T
  Mean ± SD 2243 ± 225 1919 ± 229 20.1 ± 8.4 24,964 ± 20,298 2262 ± 164 0.215 ± 0.043
  N 10 11 11 8 10 12
  p 0.100 0.538 0.944 0.028 0.004 0.779
Medulla
 1.5 T
  Mean ± SD 1987 ± 267 1884 ± 76 17.5 ± 5.5 57,350 ± 25,505 2348 ± 589 0.425 ± 0.079
  N 8 7 7 4 4 4
 3.0 T
  Mean ± SD 2031 ± 227 1796 ± 228 18.0 ± 7.8 29,016 ± 19,272 2092 ± 162 0.335 ± 0.082
  N 9 11 11 8 10 12
  p 0.721 0.261 0.877 0.110 0.452 0.105
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Table 3  Summary of survey results on agree/disagree questions
All responses W/o abstentions Choice
Question % Agree
% 
No basis
% 
Disagree % Agree % Disagree
Diet needs to be controlled before the scan
33.3 28.6 38.1 46.7 53.3
Subject should be scanned in a normal hydration 
status when clinically appropriate
76.2 19.1 4.8 94.1 5.9 Agree
Subjects are required to follow a controlled and 
standardized salt intake before the scan
4.8 42.9 52.4 8.3 91.7 Disagree
Single-shot echo planar imaging sequence
100 0 0 100 0 Agree
Multi-shot echo planar imaging sequence
28.6 33.3 38.1 42.9 57.1
RF body  matrix coils
95.2 4.8 0 100 0 Agree
Axial slice orientation
28.6 4.8 66.7 30 70 Disagree
Coronal slice orientation (consistent with above)
42.9 9.5 47.6 47.4 52.6
Oblique coronal slice orientation along long kidney 
axis (consistent with above)
76.2 0 23.8 76.2 23.8 Agree
Acquired matrix size >128
85.7 0 14.3 85.7 14.3 Agree
Inplane resolution 2 mm or smaller
19.1 0 81.0 19.1 81.0 Disagree
Inplane resolution between 2 and 3 mm
90.5 0 9.5 90.5 9.5 Agree
Inplane resolution > 3 mm
4.8 9.5 85.7 5.3 94.7 Disagree
Slice thickness 2 mm or less
0 9.5 90.5 0 100 Disagree
Slice thickness between 2 and  4 mm
57.1 4.8 38.1 60 40 Agree
Slice thickness > 4 mm
61.9 0 38.1 61.9 38.1 Agree
Gap between slices 
42.9 4.8 52.4 45 55  
Full kidney slice coverage 
90.5 0 9.5 90.5 9.5 Agree 
Parallel imaging acceleration (factor 2) 
95.2 0 4.8 95.2 4.8 Agree 
Parallel imaging acceleration (factor > 2) (consistent 
with above) 
19.1 23.81 57.1 25 75 Disagree 
 
      
SPAIR fat suppression 
61.9 23.8 14.3 81.3 18.8 Agree 
STIR fat suppression (consistent with above) 
9.5 28.6 61.9 13.3 86.7 Disagree 
 
      
2000 ms< TR < 4000 ms 
66.7 0 33.3 66.7 33.3 Agree 
TR > 4000 ms 
38.1 4.8 57.1 40 60 Disagree 
 
      
TE < 100 ms 
95.2 0 4.8 95.2 4.8 Agree 
TE minimum allowed by hardware / sequence 
85.7 9.5 4.8 94.7 5.3 Agree 
 
      
2 signal averages 
38.1 4.8 57.1 40 60 Disagree 
3 signal averages 
66.7 0 33.3 66.7 33.3 Agree 
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Table 3  (continued)
Separate acquisitions for ADC / IVIM vs. DTI studies 
in a multiparametric protocol 
42.9 9.5 47.6 47.4 52.6  
Separate protocols for multiparametric acquisitions and 
exploratory renal diffusion MRI research 
47.6 4.8 47.6 50 50  
Single protocol to provide all metrics (ADC, DTI, 
IVIM) 
47.6 14.3 38.1 55.6 44.4  
 
      
Monopolar diffusion gradients 
57.1 19.1 23.8 70.6 29.41 Agere 
Twice-refocused Bipolar diffusion gradients 
28.6 42.9 28.6 50 50  
 
      
DWI sequence with only 2 b-values 
14.3 0 85.7 14.3 85.7 Disagree 
DWI sequence with more than 2 b-values 
90.5 0 9.5 90.5 9.5 Agree 
 
      
ADC studies : include low b-values < 200 s/mm2 
85.7 0 14.3 85.7 14.3 Agree 
 
      
ADC studies : highest b-value 600 s/mm2  
19.1 0 81.0 19.1 81.0 Disagree 
ADC studies : highest b-value 800 s/mm2 (consistent 
with above)  
61.9 0 38.1 61.9 38.1 Agree 
ADC studies : high b-value 1000 s/mm2 (consistent 
with above) 
28.6 4.8 66.7 30 70 Disagree 
 
      
IVIM studies : 4 b-values 
0 9.5 90.5 0 100 Disagree 
IVIM studies : 6 b-values 
19.1 9.5 71.4 21.1 78.9 Disagree 
IVIM studies : 8 b-values 
47.6 9.5 42.9 52.6 47.4  
IVIM studies : > 8 b-values 
52.4 4.8 42.9 55 45  
 
      
DTI studies : 2 b-values 
38.1 28.6 33.3 53.3 46.7  
DTI studies: > 2 b-values 
38.1 38.1 23.81 61.51 38.5 Agree 
Expiration Breathhold acquisition 
9.5 4.8 85.7 10 90 Disagree 
Free breathing acquisition  (consistent with above) 
66.7 0 33.3 66.7 33.3 Agree 
Respiratory gated acquisition (consistent with above) 
66.7 4.8 28.6 70 30 Agree 
 
      
Cardiac gating (systole) 
0 33.3 66.7 0 100 Disagree 
Cardiac gating (diastole) 
4.8 33.3 61.9 7.1 92.9 Disagree 
 
      
 
      
DTI studies : highest b-value 400 s/mm2 
4.8 28.6 66.7 6.7 93.3 Disagree 
DTI studies : highest b-value 600 s/mm2 
47.6 19.1 33.3 58.8 41.2  
DTI studies : highest b-value 800 s/mm2 
38.1 23.8 38.1 50 50  
DTI studies : highest b-value 1000 s/mm2 
9.5 28.6 61.9 13.3 86.7 Disagree 
 
      
DTI studies : 6 directions 
19.1 19.1 61.91 23.51 76.5 Disagree 
DTI studies : 12 directions 
42.9 28.6 28.6 60 40 Agree 
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Table 3  (continued)
DTI studies : > 12 directions
47.6 23.8 28.6 62.5 37.5 Agree
Post-hoc EPI distortion correction
52.4 38.1 9.5 84.6 15.4 Agree
Post-hoc motion correction / registration
90.5 9.5 0 100 0 Agree
Unilateral motion correction / registration
47.6 38.1 14.3 76.9 23.1 Agree
Manual ROI placement
85.7 9.5 4.8 94.7 5.3 Agree
Manual ROI placement on ADC map
42.9 9.5 47.6 47.4 52.6
Manual ROI placement on b0
76.2 9.5 14.3 84.2 15.8 Agree
Manual ROI placement on FA map
42.9 14.3 42.9 50 50
Manual continuous cortical stripe ROI per slice
47.6 19.1 33.3 58.8 41.2
Manual Whole medulla ROI per slice
23.8 19.1 57.1 29.4 70.6 Disagree
Manual Whole kidney ROI per slice
33.3 14.3 52.4 38.9 61.1 Disagree
Manual Multiple medulla ROI per slice
76.2 9.5 14.3 84.2 15.8 Agree
Manual Multiple cortical ROIs per slice
52.4 9.5 38.1 57.9 42.1
If multiple, Three cortical ROIs per slice
38.1 19.1 42.9 47.1 52.9
If multiple, Three medulla ROIs per slice
47.6 19.1 33.3 58.8 41.2
If multiple, >Three cortical ROIs per slice
28.6 14.3 57.1 33.3 66.7 Disagree
If multiple, >Three medullary ROIs per slice
33.3 14.3 52.4 38.9 61.1 Disagree
If multiple slices, 3 slices sampled
52.4 9.5 38.1 57.9 42.1
If multiple slices, >3 slices sampled
57.1 9.5 33.3 63.2 36.8 Agree
Automatic ROI placement, based on b0 histogram
23.8 38.1 38.1 38.5 61.5 Disagree
Automatic ROI placement, based on ADC 
histogram
14.3 42.9 42.9 25 75 Disagree
Automatic ROI placement, based on FA histogram
19.1 42.9 38.1 33.3 66.7 Disagree
Report diffusion biomarkers in cortex
95.2 4.8 0 100 0 Agree
Report diffusion biomarkers in medulla
90.5 9.5 0 100 0 Agree
Report diffusion biomarkers in whole kidney
38.1 14.3 47.6 44.4 55.6
Diffusion units 10^-3 mm2/s
81.0 0 19.1 81.0 19.1 Agree
Diffusion units 10^-6 mm2/s
28.6 0 71.4 28.6 71.4 Disagree
Diffusion units microns^2/ms
14.3 0 85.7 14.3 85.7 Disagree
Colormap presentation
76.2 0 23.8 76.2 23.8 Agree
Grayscale map presentation
61.9 0 38.1 61.9 38.1 Agree
Parametric map fusion with anatomic imaging
61.9 9.5 28.6 68.4 31.6 Agree
Questions highlighted in bold achieved consensus (≥ 75%). The choice on each question (agree or disagree) is labeled and color coded; 
green = consensus (≥ 75%); orange = preference (≥ 60%); red = indeterminate
189Magnetic Resonance Materials in Physics, Biology and Medicine (2020) 33:177–195 
1 3
to enable reasonable comparison of analogous MRI bio-
markers (e.g., ADC and MD) in future datasets. Taking all 
of this into account, we recommend the following b value 
sets (Table 4): for monoexponential DWI studies, b = 0, 100, 
200, 800 s/mm2, 3 directions; for IVIM studies b = 0, 30, 
70, 100, 200, 400, 800 s/mm2, 3 directions; for DTI studies, 
b = 0, 200, 800 s/mm2, 12 or more directions.
Manual ROI placement had consensus support over 
automatic (e.g., histogram-based) placement, with the 
unweighted (b = 0) image having consensus support for ROI 
prescription. Cortical ROIs should be continuous stripes 
(one per slice), unless structural abnormalities prevent this, 
while medullary ROIs should be separate, with three regions 
sampled (upper, middle, lower poles). Generally, all slices 
from whole kidney coverage should be sampled with the 
exception of the two outermost slices where region deline-
ation may be unclear. The consensus support for manual 
ROI placement is also interesting given the recent trend for 
machine learning (ML) and artificial intelligence (AI) in the 
medicine. Some efforts were made recently to adopt these 
techniques to renal DWI, especially in the detection of early 
acute renal allograft rejection [90–93]. However, great care 
is needed when trying to translate these approaches into the 
clinical arena, particularly in terms of clinical validation and 
measured patient-centric outcomes. We are confident that 
these techniques will play an important part in subsequent 
Table 4  Recommendations for acquisition and processing of renal DWI data
Protocol option Recommendation Weight
Preparation Normal hydration
Field strength 1.5 T or 3.0 T
Sequence Single shot EPI
Orientation Oblique coronal
Matrix >128
In-plane resolution 2-3 mm
Slice thickness >4 mm
Coverage Full kidney
Parallel imaging 
factor 2
Fat suppression SPAIR
TR (s) 4
TE (ms) Min ( < 100)
Averages 3
Breathing mode Respiratory gated 
(or free breathing with post-hoc motion correction)
Cardiac gating no
Diffusion gradients Monopolar
ADC IVIM DTI
# b-values 4 >6 >2
Suggested b-values 0,100,200,800 0,30,70,100,200,400,800 0,200,800
# directions 3 3 12 or more
Time (min) 2 3.8 5
Distortion 
correction Recommended
Registration Recommended, unilateral if possible
Image quality 
control Recommended
ROI placement b=0 image
Cortical ROI 1 stripe / slice ;> 3 slices
Medullary ROI 3 samples / slice ;> 3 slices
Reporting Cortex and Medulla
Metric statistics 
reporting Mean, Median, Standard deviation, ROI size
Diffusion units 10-3 mm2 / s
Map format Colormap , fused with anatomy if possible
Recommendations in bold are derived from consensus view of the expert panel. Weight of each recommendation is color coded (green = consen-
sus (≥ 75%); orange = preference (≥ 60%)
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research studies, influence clinical translation and consti-
tute a major focus for discussion in future versions of these 
recommendations.
We acknowledge some limitations in the procedures used 
to generate recommendations in this work. First, all entries 
in the literature review were assigned equal weight irrespec-
tive of population size or technological availability. Hetero-
geneity also exists in the survey process, in which participant 
elections may have been driven by different priorities and 
informed by different levels of clinical or technical experi-
ence. In addition, while we modeled our approach on the 
Delphi consensus procedure, its application was adjusted for 
the purposes of this review and its timeframe. The survey 
also highlighted other areas of disagreement between the 
participants. In particular, it was not possible to obtain a 
consensus on technical questions like the use of segmented 
echo planar acquisitions, or the advantage of bipolar dif-
fusion gradients. We have not included a strategy of noise 
correction (pure Rician or otherwise) for more accurate 
quantification, but practical approaches exist that may be 
amenable to broad guidelines in a future iteration [85]. We 
also acknowledge that the imaging gradient contributions 
to the nominally unweighted (b = 0) image might lead to a 
potential source of error, especially in assessing f and D*. 
The full effect of this source of error has yet to be evalu-
ated in the kidney literature. This work summarizes the large 
evidence base for a nonzero perfusion fraction, but the next 
level of standardization might refine processing to take full 
b matrices into account [94, 95].
We have also not issued a standardized prescription 
for phantom quality control, which has proven beneficial 
to DWI standardization efforts in other contexts [96, 97]; 
the choice of and agreement upon such a phantom for renal 
DWI can be revisited in the next standardization iteration. 
Uncertainty exists also for physiological questions such as 
the effect of diet on DWI. As some of these issues have 
already been partly addressed in the literature, the survey 
indicates that currently available evidence may not be suffi-
cient for conclusive resolution. This report should, therefore, 
motivate a significant effort to investigate these dedicated 
methodological questions.
Conclusions
The present work has summarized trends in the literature 
of renal diffusion MRI to date and their correlation with 
aspects of protocol design to direct future research efforts 
in the field of renal DWI. In pursuit of minimizing inter-
study and inter-site variation, for the generation of evidence 
basis for reliable and high impact of imaging markers for 
renal disease, and with the guidance of a Delphi-based con-
sensus process of experts in the field, we have generated a 
set of recommendations for future data collection. The rec-
ommended protocols have been chosen to be achievable by 
any center with clinical MRI capabilities and enable future 
multicentre pooling of data when equivalent protocols have 
been used. Therefore, these recommendations should be 
taken into account when starting new studies in the field of 
renal DWI and when reviewing submitted work in this area. 
We expect this recommendation process to be an iterative 
one and ensuing efforts may refine or add to these recom-
mendations. To allow both growth and innovation in the 
field, as well as harmonization, “deviations” from these 
recommendations should be justified in the future studies 
and submissions for publication. There recommendations 
are intended to be updated when new evidence from ongo-
ing or future studies is made available and change any of the 
recommended parameters.
Importantly, these translational efforts do not replace 
and are not in conflict with ongoing innovation efforts to 
uncover more specific biomarkers from renal DWI with 
more advanced methods. Instead, they reflect a view that 
commitment toward producing generalizable workflows in 
parallel will yield tremendous benefits to the field as a whole 
and increase chances of clinical impact on a larger scale.
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